Supplier profile
Alexion Pharma Spain, S.L.U
Every public-sector award we hold for this supplier, across Spain, from 23 Mar 2012 to 9 Oct 2026.
Awards won
23
all time
Attributed value
€27.0m
3 shared, unvalued
Buyers
14
public bodies
Active
2012–2026
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| HOSPITAL CLINICO SAN CARLOS DE MADRID | 6 | €5.5m |
| Servicio Cántabro de Salud | 3 | €7.7m |
| HOSPITAL UNIVERSITARIO PRINCIPE DE ASTURIAS | 2 | €1.4m |
| Servicio Madrileno de Salud, Hospital Universitario La Paz | 2 | €3.1m |
| CONSORCI HOSPITAL CLÍNIC DE BARCELONA (HCB) | 1 | not attributable |
| Consejería de Sanidad. Empresa Pública Hospital del Norte (Hospital Infanta Sofía) | 1 | €1.3m |
| Consorci de Salut i d'Atenció Social de Catalunya | 1 | not attributable |
| ENTE PUBLICO HOSPITAL UNIVERSITARIO DE FUENLABRADA | 1 | €1.3m |
| ENTE PÚBLICO HOSPITAL UNIVERSITARIO DE FUENLABRA | 1 | €2.3m |
| Empresa Pública Hospital del Norte (Hospital Universitario Infanta Sofía) | 1 | €694k |
What they win
Awards
All 23 awards we hold
- Spain – Immunosuppressive agents – PNSP HUPA 96/26 ↗HOSPITAL UNIVERSITARIO PRINCIPE DE ASTURIAS€693kawarded 9 Oct 2026
- Spain – Immunosuppressive agents – LOT-0001 ↗HOSPITAL UNIVERSITARIO PRINCIPE DE ASTURIAS€720kawarded 6 Oct 2026
- Spain – Pharmaceutical products – 7ª Prórroga + MODIFICACION Suministro de RAVULIZUMAB (ULTOMIRIS) solución inyectable, de distribución exclusiva para el Servicio de Farmacia del Hospital Clínico San Carlos de Madrid. ↗HOSPITAL CLINICO SAN CARLOS DE MADRID€2.0mawarded 3 Oct 2026
- Spain – Various medicinal products – 2026-94 Suministro de medicamentos exclusivos diversos de Alexion Pharma Spain, S.L. ↗CONSORCI HOSPITAL CLÍNIC DE BARCELONA (HCB)shared awardawarded 6 Aug 2026
- Suministro de medicamentos sin competencia para los hospitales del Servicio Cántabro de Salud (medicamentos Ravulizumab (Ultomiris) y Selumetinib (Koselugo)). (AM PN SCS 2025/144).


 ↗Servicio Cántabro de Salud€921kawarded 4 Aug 2026
- Spain – Various medicinal products – ACUERDO MARCO DE SUMINISTRO DE MEDICAMENTOS ONCOLÓGICOS ↗Consorci de Salut i d'Atenció Social de Catalunyashared awardawarded 15 Jul 2026
- Spain – Various medicinal products – SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS RAVULIZUMAB DE ALEXION PHARMA SPAIN, S.L., PARA EL HOSPITAL UNIVERSITARIO DE FUENLABRADA ↗ENTE PÚBLICO HOSPITAL UNIVERSITARIO DE FUENLABRA€2.3mawarded 9 Jul 2026
- Spain – Pharmaceutical products – Acuerdo Marco para el Suministro de medicamentos sin competencia para los hospitales del Servicio Cántabro de Salud (Medicamentos Ravulizumab (Ultomiris) y Selumetinib (Koselugo)). ↗Servicio Cántabro de Saludawarded 20 Jun 2026
- Acuerdo Marco para el Suministro de medicamentos sin competencia para los hospitales del Servicio Cántabro de Salud (Medicamentos Ravulizumab (Ultomiris) y Selumetinib (Koselugo)).
 ↗Servicio Cántabro de Salud€6.8mawarded 19 Jun 2026
- Spain – Pharmaceutical products – Suministro del medicamento exclusivo: Ravulizumab (ULTOMIRIS). ↗Servicio Madrileno de Salud, Hospital Universitario La Paz€2.6mawarded 28 May 2026
- Spain – Pharmaceutical products – 6ª Prórroga Suministro de RAVULIZUMAB (ULTOMIRIS) solución inyectable, de distribución exclusiva para el Servicio de Farmacia del Hospital Clínico San Carlos de Madrid. ↗HOSPITAL CLINICO SAN CARLOS DE MADRID€691kawarded 3 Apr 2026
- Spain – Pharmaceutical products – SUMINISTRO DE ULTOMIRIS Y VOYDEYA DISTRIBUIDOS EN EXCLUSIVIDAD POR EL LABORATORIO ALEXION PHARMA SPAIN.S.A.U ↗HOSPITAL UNIVERSITARIO PUERTA DE HIERRO MAJADAHONDA€2.9mawarded 24 Mar 2026
- Spain – Pharmaceutical products – SUMINISTRO MEDICAMENTOS EXCLUSIVOS: SEBELIPASA ALFA (KANUMA) Y RAVULIZUMAB (ULTOMIRIS). ↗Servicio Madrileno de Salud, Hospital Universitario La Paz€447kawarded 28 Nov 2025
- Spain – Pharmaceutical products – 5ª Prórroga Suministro de RAVULIZUMAB (ULTOMIRIS) solución inyectable, de distribución exclusiva para el Servicio de Farmacia del Hospital Clínico San Carlos de Madrid. ↗HOSPITAL CLINICO SAN CARLOS DE MADRID€691kawarded 3 Oct 2025
- Spain – Pharmaceutical products – 4ª Prórroga Suministro de RAVULIZUMAB (ULTOMIRIS) solución inyectable, de distribución exclusiva para el Servicio de Farmacia del Hospital Clínico San Carlos de Madrid. ↗HOSPITAL CLINICO SAN CARLOS DE MADRID€691kawarded 6 Apr 2025
- Spain – Pharmaceutical products – 3ª Prórroga Suministro de RAVULIZUMAB (ULTOMIRIS) solución inyectable, de distribución exclusiva para el Servicio de Farmacia del Hospital Clínico San Carlos de Madrid. ↗HOSPITAL CLINICO SAN CARLOS DE MADRID€691kawarded 6 Oct 2024
- Spain – Pharmaceutical products – 2ª Prórroga Suministro de RAVULIZUMAB (ULTOMIRIS) solución inyectable, de distribución exclusiva para el Servicio de Farmacia del Hospital Clínico San Carlos de Madrid. ↗HOSPITAL CLINICO SAN CARLOS DE MADRID€691kawarded 6 Apr 2024
- Spain – Pharmaceutical products – SUMINISTRO DE FÁRMACOS EXCLUSIVOS Y/O NO SUSTITUÍBLES ↗Fundació de Gestió Sanitària de l’Hospital de la Santa Creu i Sant Pau.shared awardawarded 6 Mar 2024
- Prorroga del expediente PN 434/21 de suministro del medicamento exclusivo Eculizumab para los centros dependientes del Servicio de Salud de las Islas Baleares ↗Servicio de Salud de las Illes Balears€480kawarded 6 Jun 2023
- Spain-Fuenlabrada: Pharmaceutical products ↗ENTE PUBLICO HOSPITAL UNIVERSITARIO DE FUENLABRADA€1.3mawarded 13 Mar 2023
- Eculizumab 10 mg/ml vial 30 ml c/1 ↗Hospital General Universitario Gregorio Marañón€374kawarded 15 Jun 2016
- Medical equipment, pharmaceuticals & personal care — Consejería de Sanidad. Empresa Pública Hospital del Norte (Hospital Infanta Sofía) ↗Consejería de Sanidad. Empresa Pública Hospital del Norte (Hospital Infanta Sofía)€1.3mawarded 3 Jul 2014
- Suministro de anticuerpo IgG monoclonal humanizado para el tratamiento de hemoglobinuria paroxística nocturna. ↗Empresa Pública Hospital del Norte (Hospital Universitario Infanta Sofía)€694kawarded 23 Mar 2012
Possibly the same organisation
These entries differ from this one only by legal form or a bracketed qualifier, so they may be the same organisation — or a different registered company of the same name. They are kept apart on purpose: the figures on each page are per legal entity and are never combined.
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.